SEOM clinical guidelines for the adjuvant treatment of colorectal cancer

Clinical and Translational Oncology

Volumn 12, Issue 11, 2010, Pages 724-728

  Grávalos Castro, Cristina ^j   Maurel Santasusana, Joan ^a   Rivera Herrero, Fernando ^b   Salazar Soler, Ramón ^c   Sevilla García, Isabel ^d   Sastre Valera, Javier ^e   Tabernero Caturla, José M ^f   González Flores, Encarnación ^g   Lomas Garrido, María ^h   Isla Casado, Dolores ⁱ  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^h Hospital Universitario Medico Quirurgico   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

more..

Author keywords

Colorectal cancer; Diagnosis; Guidelines; SEOM; Treatment

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; UFT;

ANTIGEN DETECTION; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRACTICE GUIDELINE; RECTUM BIOPSY; REVIEW; SPANISH SOCIETY OF MEDICAL ONCOLOGY; TREATMENT DURATION; TREATMENT RESPONSE;

ALGORITHMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; SOCIETIES, MEDICAL; SPAIN;

EID: 78649658564     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0586-5     Document Type: Review

References (23)

1. F.L. Greene A.K. Stewart H.J. Norton 2002 A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients Ann Surg 236 416 421 10.1097/00000658-200210000-00003 12368669
2. R.G. Beets-Tan G.L. Beets R.F. Vliegen, et al. 2001 Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery Lancet 357 497 504 1:STN:280:DC%2BD3M7lt1Shtg%3D%3D 10.1016/S0140-6736(00)04040-X 11229667 (Pubitemid 32173585)
3. N.N. Baxter D.J. Virnig D.A. Rothenberger, et al. 2005 Lymph node evaluation in colorectal cancer patients: a population-based study J Natl Cancer Inst 97 219 225 10.1093/jnci/dji020 15687365 (Pubitemid 40277372)
4. M. Buunen R. Veldkamp W.C. Hop, et al. 2009 Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Colon Cancer Laparoscopic or Open Resection Study Group Lancet Oncol 10 44 52 10.1016/S1470-2045(08)70310-3 19071061
5. T. André C. Boni M. Navarro, et al. 2009 Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109 3116 10.1200/JCO.2008.20.6771 19451431
6. N. Wolmark S. Wieand J.P. Kueber, et al. 2008 A phase III trial comparing 5FULV to FULV+oxaliplatin in stage II or III carcinoma of the colon: survival results of NSABP Protocol C-07 J Clin Oncol 26 [15s] LBA4005
7. Haller D, Tabernero J, Maroun J et al (2009) Adjuvant treatment with capecitabine and oxaliplatin (XELOX) in stage III colon cancer. ESMO/ECCO Presidential Session III, Berlin
8. Jackson McCleary NA, Meyerhardt J, Green E et al (2009) Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT Database. J Clin Oncol 27[15s]:abstr 4010
9. B.C. Lembersky S. Wieand N.J. Petrelli, et al. 2006 Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06 J Clin Oncol 24 2059 2064 1:CAS:528:DC%2BD28Xlt1amurk%3D 10.1200/JCO.2005.04.7498 16648506 (Pubitemid 46622115)
10. C. Twelves A. Wong M.P. Nowacki, et al. 2005 Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 2696 2704 1:CAS:528:DC%2BD2MXls1SktL0%3D 10.1056/NEJMoa043116 15987918 (Pubitemid 41007824)
11. L.B. Saltz D. Niedzwiecki D. Hollis, et al. 2007 Irinotecan fluorouracil plus leucovorin is not superior to fluoruracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803 J Clin Oncol 25 3456 3461 1:CAS:528:DC%2BD2sXhtVajsbzP 10.1200/JCO.2007.11.2144 17687149 (Pubitemid 47310883)
12. E. Van Cutsem R. Labianca G. Bodoky, et al. 2009 Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 J Clin Oncol 27 3117 3125 10.1200/JCO.2008.21.6663 19451425
13. N. Wolmark G. Yothers M.J. O'Connell, et al. 2009 A phase III trial comparing FOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: results of NSABP Protocol C-08 J Clin Oncol 27 [15S] LBA4
14. A.B. Benson 3rd D. Schrag M.R. Somerfield, et al. 2004 American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408 3419 10.1200/JCO.2004.05.063 15199089 (Pubitemid 41103700)
15. E. Kapiteijn C.A. Marijnen I.D. Nagtegaal, et al. 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638 646 1:STN:280:DC%2BD3Mvps1ektw%3D%3D 10.1056/NEJMoa010580 11547717
16. L. Collete J.F. Bosset M. den Dulk, et al. 2007 Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group J Clin Oncol 25 4379 4386 10.1200/JCO.2007.11. 9685 (Pubitemid 350013843)
17. R. Sauer H. Becker W. Hohenberger, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 1740 1:CAS:528:DC%2BD2cXovFSksbo%3D 10.1056/NEJMoa040694 15496622 (Pubitemid 39383208)
18. J.F. Bosset L. Collette G. Calais, et al. 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114 1123 1:CAS:528:DC%2BD28XpsFKkur8%3D 10.1056/NEJMoa060829 16971718 (Pubitemid 44394918)
19. J. Gerard D. Azria S. Gourgou-Bourgade, et al. 2009 Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients with locally advanced rectal cancer (LARC): results of the ACCORD 12/0405 PRODIGE 2 J Clin Oncol 27 [15S] LBA 4007
20. C. Aschele S. Pinto S. Cordio, et al. 2009 Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial J Clin Oncol 27 [15S] CRA4008
21. C. Fernández-Martos C. Pericay J. Aparicio, et al. 2010 Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cáncer de Recto 3 Study J Clin Oncol 28 859 865 10.1200/JCO.2009.25.8541 20065174
22. M. Jeffery B.E. Hickey P.N. Hider 2007 Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database Syst Rev 1 CD002200 17253476
23. D.K. Rex C.J. Kahi B. Levin, et al. 2006 Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 130 1865 1871 10.1053/j.gastro.2006.03.013 16697749 (Pubitemid 43668858)